Blood-based metabolic signatures in Alzheimer's disease

INTRODUCTION: Identification of blood-based metabolic changes might provide early and easy-to-obtain biomarkers. METHODS: We included 127 Alzheimer's disease (AD) patients and 121 control subjects with cerebrospinal fluid biomarker-confirmed diagnosis (cutoff tau/amyloid β peptide 42: 0.52). Ma...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Alzheimers Dement (Amst)
Asıl Yazarlar: de Leeuw, Francisca A., Peeters, Carel F.W., Kester, Maartje I., Harms, Amy C., Struys, Eduard A., Hankemeier, Thomas, van Vlijmen, Herman W.T., van der Lee, Sven J., van Duijn, Cornelia M., Scheltens, Philip, Demirkan, Ayşe, van de Wiel, Mark A., van der Flier, Wiesje M., Teunissen, Charlotte E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2017
Konular:
Blood-Based Biomarkers
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5607205/
https://ncbi.nlm.nih.gov/pubmed/28951883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2017.07.006
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller